BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2435550)

  • 21. The ways in which hormones change cyclic adenosine 3',5'-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior.
    Spaulding SW
    Endocr Rev; 1993 Oct; 14(5):632-50. PubMed ID: 8262010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C gamma subunit is a unique isozyme of the cAMP-dependent protein kinase.
    Beebe SJ; Salomonsky P; Jahnsen T; Li Y
    J Biol Chem; 1992 Dec; 267(35):25505-12. PubMed ID: 1334096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isozymes of cAMP-dependent protein kinase present in the rat corpus luteum.
    Hunzicker-Dunn M; Cutler RE; Maizels ET; DeManno DA; Lamm ML; Erlichman J; Sanwal BD; LaBarbera AR
    J Biol Chem; 1991 Apr; 266(11):7166-75. PubMed ID: 1849902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides.
    Cadd GG; Uhler MD; McKnight GS
    J Biol Chem; 1990 Nov; 265(32):19502-6. PubMed ID: 2174040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A point mutation abolishes binding of cAMP to site A in the regulatory subunit of cAMP-dependent protein kinase.
    Bubis J; Neitzel JJ; Saraswat LD; Taylor SS
    J Biol Chem; 1988 Jul; 263(20):9668-73. PubMed ID: 2898473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cyclic AMP-requiring yeast mutants altered in the regulatory subunit of protein kinase.
    Uno I; Matsumoto K; Ishikawa T
    J Biol Chem; 1982 Dec; 257(23):14110-5. PubMed ID: 6292221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of types I and II adenosine cyclic 3',5'-phosphate dependent protein kinase.
    Bohnert JL; Malencik DA; Anderson SR; Teller D; Fischer EH
    Biochemistry; 1982 Oct; 21(22):5563-70. PubMed ID: 6293546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of cAMP-dependent protein kinase subunit levels in Friend erythroleukemic cells. Effects of differentiation and treatment with 8-Br-cAMP and methylisobutyl xanthine.
    Schwartz DA; Rubin CS
    J Biol Chem; 1983 Jan; 258(2):777-84. PubMed ID: 6185479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A structural gene mutation affecting the regulatory subunit of cyclic AMP-dependent protein kinase in mouse lymphoma cells.
    Hochman J; Insel PA; Bourne HR; Coffino P; Tomkins GM
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):5051-5. PubMed ID: 174091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Active site mutations define the pathway for the cooperative activation of cAMP-dependent protein kinase.
    Herberg FW; Taylor SS; Dostmann WR
    Biochemistry; 1996 Mar; 35(9):2934-42. PubMed ID: 8608131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
    Yu S; Mei FC; Lee JC; Cheng X
    Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cAMP-dependent protein kinase regulates renal epithelial cell properties.
    Amsler K; Ghatani S; Hemmings BA
    Am J Physiol; 1991 Jun; 260(6 Pt 1):C1290-9. PubMed ID: 1711777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of adrenocortical adenosine 3',5'-monoposphate-dependent protein kinases.
    Ahrens H; Aiyar NV; Sharma RK
    Endocrinology; 1986 Jun; 118(6):2168-79. PubMed ID: 3009153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The causal relationship between mutations in cAMP-dependent protein kinase and the loss of adrenocorticotropin-regulated adrenocortical functions.
    Wong M; Krolczyk AJ; Schimmer BP
    Mol Endocrinol; 1992 Oct; 6(10):1614-24. PubMed ID: 1333050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of two adenosine 3',5'-monophosphate-dependent protein kinases from bovine adrenal cortex.
    Ebert RF; Finn FM
    Endocrinology; 1981 Jul; 109(1):197-204. PubMed ID: 6263584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations that prevent cyclic nucleotide binding to binding sites A or B of type I cyclic AMP-dependent protein kinase.
    Ogreid D; Døskeland SO; Gorman KB; Steinberg RA
    J Biol Chem; 1988 Nov; 263(33):17397-404. PubMed ID: 2846564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-elution of type I and type II cAMP-dependent protein kinase holoenzymes in high salt fractions from DEAE-cellulose.
    Butley MS; Malkinson AM
    J Biol Chem; 1984 May; 259(9):6001-7. PubMed ID: 6715383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
    Hamuro Y; Anand GS; Kim JS; Juliano C; Stranz DD; Taylor SS; Woods VL
    J Mol Biol; 2004 Jul; 340(5):1185-96. PubMed ID: 15236976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA-mediated gene transfer of a mutant regulatory subunit of cAMP-dependent protein kinase.
    Abraham I; Brill S; Hyde J; Fleischmann R; Chapman M; Gottesman MM
    J Biol Chem; 1985 Nov; 260(26):13934-40. PubMed ID: 2997188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence resonance energy transfer within a heterochromatic cAMP-dependent protein kinase holoenzyme under equilibrium conditions: new insights into the conformational changes that result in cAMP-dependent activation.
    Johnson DA; Leathers VL; Martinez AM; Walsh DA; Fletcher WH
    Biochemistry; 1993 Jun; 32(25):6402-10. PubMed ID: 8390856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.